Thian Kheoh
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology
Most-Cited Works
- → Abiraterone and Increased Survival in Metastatic Prostate Cancer(2011)4,364 cited
- → Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy(2012)2,765 cited
- → Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer(2017)2,163 cited
- → Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study(2012)1,374 cited
- → Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study(2015)1,334 cited
- → Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation(2022)908 cited
- → Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer(2009)600 cited
- → Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C(2022)447 cited
- → Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer(2010)409 cited
- → Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate(2010)394 cited